Table 4.
Comparison of ΔMAS,ΔFMA and ΔMBI scores between the two groups (duration of the disease 7–12 months)
| Outcomes | CR | TN | Between 2 groups | |
|---|---|---|---|---|
| z | P‐value | |||
| ΔMAS‐Elbow flexors muscle | ||||
| Baseline‐WK2 | 0.13 ± 0.47 (−0.02, 0.28) | 0.20 ± 0.41 (0.03, 0.37) | 0.80 | 0.3721 |
| Baseline‐WK4 | 0.42 ± 0.55 (0.24, 0.60) | 0.60 ± 0.71 (0.31, 0.89) | 0.84 | 0.3598 |
| Baseline‐MTH3 | 0.30 ± 0.77 (0.03, 0.58) | 0.56 ± 0.58 (0.32, 0.80) | 2.00 | 0.1577 |
| Baseline‐MTH6 | 0.18 ± 0.66 (0.09, 0.28) | 0.27 ± 0.57 (0.19, 0.35) | 3.63 | 0.0567 |
| ΔMAS‐Wrist flexors muscle | ||||
| Baseline‐WK2 | 0.13 ± 0.34 (0.02, 0.24) | 0.20 ± 0.50 (−0.01, 0.41) | 0.17 | 0.6812 |
| Baseline‐WK4 | 0.32 ± 0.66 (0.10, 0.53) | 0.60 ± 0.65 (0.33, 0.87) | 3.76 | 0.0525 |
| Baseline‐MTH3 | 0.27 ± 0.67 (0.03, 0.51) | 0.56 ± 0.65 (0.29, 0.83) | 2.25 | 0.1335 |
| Baseline‐MTH6 | 0.39 ± 0.74 (0.11, 0.68) | 0.64 ± 0.70 (0.35, 0.93) | 1.97 | 0.1606 |
| ΔMAS‐Finger flexors muscle | ||||
| Baseline‐WK2 | 0.21 ± 4.54 (−0.42, 0.84) | 0.16 ± 4.08 (−0.41, 0.73) | 0.01 | 0.9038 |
| Baseline‐WK4 | 0.39 ± 4.49 (−0.24, 1.02) | 0.11 ± 4.65 (−0.55, 0.76) | 0.37 | 0.5428 |
| Baseline‐MTH3 | 0.68 ± 5.38 (−0.11, 1.47) | 0.63 ± 4.76 (−0.08, 1.33) | 0.01 | 0.9220 |
| Baseline‐MTH6 | 0.79 ± 5.48 (−0.08, 1.66) | 0.99 ± 5.22 (0.16, 1.83) | 0.11 | 0.7354 |
| ΔFMA‐T | ||||
| Baseline‐WK2 | −1.38 ± 6.20 (−3.39, 0.63) | −3.92 ± 5.93 (−6.37, −1.47) | 2.63 | 0.1097 |
| Baseline‐WK4 | −5.21 ± 9.78 (−8.43, −2.00) | −8.40 ± 8.50 (−11.91, −4.89) | 1.77 | 0.1877 |
| Baseline‐MTH3 | −10.24 ± 12.91 (−14.82, −5.67) | −13.96 ± 10.60 (−18.33, −9.59) | 1.37 | 0.2465 |
| Baseline‐MTH6 | −12.18 ± 17.00 (−18.77, −5.59) | −17.96 ± 13.34 (−23.47, −12.45) | 1.86 | 0.1781 |
| ΔFMA‐U | ||||
| Baseline‐WK2 | −0.64 ± 4.93 (−2.24, 0.96) | −2.96 ± 4.92 (−4.99, −0.93) | 3.38 | 0.0709 |
| Baseline‐WK4 | −3.21 ± 6.96 (−5.50, −0.92) | −6.04 ± 7.04 (−8.95, −3.13) | 2.47 | 0.1213 |
| Baseline‐MTH3 | −6.58 ± 9.25 (−9.86, −3.29) | −10.04 ± 7.79 (−13.25, −6.83) | 2.28 | 0.1368 |
| Baseline‐MTH6 | −7.64 ± 11.97 (−12.28, −3.00) | −12.80 ± 9.18 (−16.59, −9.01) | 3.04 | 0.0872 |
| ΔMBI | ||||
| Baseline‐WK2 | −1.46 ± 7.12 (−3.77, 0.84) | −1.16 ± 2.01 (−1.99, −0.33) | 0.04 | 0.8374 |
| Baseline‐WK4 | −4.50 ± 9.27 (−7.55, −1.45) | −4.76 ± 3.84 (−6.35, −3.17) | 0.02 | 0.8949 |
| Baseline‐MTH3 | −8.97 ± 11.76 (−13.14, −4.80) | −9.16 ± 8.07 (−12.49, −5.83) | 0.00 | 0.9449 |
| Baseline‐MTH6 | −9.75 ± 13.31 (−14.91, −4.59) | −10.44 ± 8.82 (−14.08, −6.80) | 0.05 | 0.8271 |
The data are presented as the mean ± standard deviation (SD), 95% CI. ΔChange in value before versus after treatment.
MAS, Modified Ashworth Scale; FMA‐U, Fugl‐Meyer upper limb score; FMA‐T, Fugl‐Meyer total score; MBI, Modified Barthel Index; WK, week; MTH, month; MTH, month. CR, Conventional rehabilitation group TN, Tui Na group.